Consulting on Common Concerns in PAH: How Would You Manage These Patients?
Program Themes
52-Year-Old Man, Diagnosed With PAH in 2012
RHC
Initial Visit at Specialty Clinic 2015
Pharmacist's Role, Initial Management
Case Study: Escalation of Therapy Indicated
Classes of Agents That Target Different Pathways in PAH
Combination Pharmacotherapy in PAH: Rationale and Potential Clinical Benefits
AMBITION Study: Primary Endpoint* Results
Tactics to Address Treatment Adherence
Tactics to Address Treatment Adherence (cont)
Follow-Up: 3 Months
Follow-Up 2 Years Later
Objective Findings at 1 Year
Pharmacist's Role Transition to Oral Prostacyclin Pathway Agent
Parenteral Therapies: Multidisciplinary Collaboration and Specialty Pharmacies
Multidisciplinary Collaboration
Conclusions
Abbreviations
Abbreviations (cont)